What is PHRRF stock price today?

PHRRF (Pharmather Holdings Ltd) stock is trading at $0.06 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is PHRRF stock going up or down today?

PHRRF stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy PHRRF stock now?

The decision to buy PHRRF depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is PHRRF a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for PHRRF based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is PHRRF stock overvalued or undervalued?

Use our DCF valuation calculator to determine if PHRRF is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is PHRRF's P/E ratio?

P/E ratio data for PHRRF will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is PHRRF's market cap?

PHRRF (Pharmather Holdings Ltd) has a market capitalization of $0.00 billion, making it a small-cap stock.

What is PHRRF's price to book ratio?

PHRRF trades at a price-to-book (P/B) ratio of 10.90, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does PHRRF pay dividends?

PHRRF does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is PHRRF's dividend yield?

PHRRF does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is PHRRF stock a good long-term investment?

PHRRF's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is PHRRF's revenue growth rate?

Revenue growth data for PHRRF is available on our dashboard with detailed financial statement analysis.

Profitability metrics for PHRRF are available on our dashboard with complete income statement analysis.

What are the risks of investing in PHRRF?

Key risks for PHRRF include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does PHRRF compare to its competitors?

Compare PHRRF to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize PHRRF's performance and positioning.

What is PHRRF's stock price target for 2026?

Our AI model provides price targets for PHRRF based on fundamental analysis: Bull case $0.08 (+30%), Base case $0.07 (+15%), Bear case $0.05 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about PHRRF?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for PHRRF. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is PHRRF's next earnings report?

PHRRF reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

PHRRF - Pharmather Holdings Ltd

NYSE * Healthcare * Biotechnology

$0.06

+$0.01 (+24.74%)

About Pharmather Holdings Ltd

PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company's product pipeline includes KETARX, a ketamine hydrochloride injection for the treatment of Parkinson's disease, Amyotrophic Lateral Sclerosis, complex regional pain, and anesthesia, procedural sedation as well as depression, surgical and pain management. It develops KETARX, a microneedle patch, for mental health, neurological, and pain disorders; and KETARX wearable pump for the maintenance of general anesthesia for diagnostic, surgical procedures and pain indications. In addition, the company offers PHARMAPATCH, a microneedle patch technology solution, which includes hydrogel-forming and gelatin methacryloyl delivery system for the treatment of psychedelics and infectious diseases. Further, it has license agreement with BioRAE, Inc. for the development and commercialization of a novel biocompatible and biodegradable gelatin methacryloyl microneedle; and the University of Kansas to develop and commercialize the intellectual property of ketamine to treat ALS; with the University of Arizona for the development and commercialization of ketamine in the treatment of Parkinson's disease; as well as holds a patent and know-how license agreement with The Queen's University of Belfast to develop and commercialize hydrogel-forming microneedle patch delivery technology. The company was incorporated in 2019 and is headquartered in Toronto, Canada.

PHRRF Key Statistics

Market Cap

$4.28M

P/B Ratio

10.90

EPS

$-0.01

How PHRRF Compares to Peers

PHRRF is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

N/A

of 5

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
PHRRF(This stock)	$4.28M	N/A	0%	0.0%	-
AMGNAmgen Inc	$191.53B	24.6	0%	0.2%	vs AMGN
GILDGilead Sciences	$170.84B	20.3	0%	0.3%	vs GILD
VRTXVertex Pharmaceuticals	$112.22B	28.8	0%	0.3%	vs VRTX
REGNRegeneron Pharmaceuticals	$79.35B	18.1	0%	0.3%	vs REGN
BIIBBiogen Inc	$26.03B	20.0	-0%	0.1%	vs BIIB

Pharmather Holdings Ltd Company Information

Headquarters: 82 Richmond Street East, Toronto, ON, Canada, M5C 1P1, undefined
Website: www.pharmather.com
Sector: Healthcare
Industry: Biotechnology

About Pharmather Holdings Ltd

PHRRF Key Statistics

How PHRRF Compares to Peers

Pharmather Holdings Ltd Company Information

Upcoming Events for PHRRF